UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes of Simultaneous Resections and Classical Strategy for Synchronous Colorectal Liver Metastases in Sweden: A Nationwide Study with Special Reference to Major Liver Resections

World journal of surgery, 2020-07, Vol.44 (7), p.2409-2417

2020

Volltextzugriff (PDF)

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation

BMC cancer, 2019-06, Vol.19 (1), p.568-568, Article 568

2019

Volltextzugriff (PDF)

Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma

Frontiers in oncology, 2019, Vol.9, p.19

2019

Volltextzugriff (PDF)

Argipressin for prevention of blood loss during liver resection: a study protocol for a randomised, placebo-controlled, double-blinded trial (ARG-01)

BMJ open, 2023-08, Vol.13 (8), p.e073270-e073270

2023

Volltextzugriff (PDF)

Characterization of brown adipose tissue in the human perirenal depot

Obesity (Silver Spring, Md.), 2014-08, Vol.22 (8), p.1830-1837

2014

Volltextzugriff (PDF)

Checkpoint Inhibition Causing Complete Remission of Metastatic Combined Hepatocellular-Cholangiocarcinoma after Hepatic Resection

Case reports in oncology, 2020-01, Vol.13 (1), p.478-484

2020

Volltextzugriff (PDF)

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer

International journal of clinical oncology, 2008-02, Vol.13 (1), p.66-70

2008

Volltextzugriff (PDF)

The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium

HPB Surgery, 2015, Vol.2015, p.736049-6

2015

Volltextzugriff (PDF)

Simulation Model of Microsphere Distribution for Selective Internal Radiation Therapy Agrees With Observations

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.414-421

2016

Volltextzugriff (PDF)

Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial

Annals of surgery open, 2024-03, Vol.5 (1), p.e367-e367

2024

Volltextzugriff (PDF)

Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities

Advances in radiation oncology, 2018-07, Vol.3 (3), p.439-446

2018

Volltextzugriff (PDF)

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

The lancet oncology, 2018-07, Vol.19 (7), p.940-952

2018

Volltextzugriff (PDF)

Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study

European journal of surgical oncology, 2021-02, Vol.47 (2), p.375-383

2021

Volltextzugriff (PDF)

ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)

Annals of surgery, 2018-05, Vol.267 (5), p.833-840

2018

Volltextzugriff (PDF)

Abstract 6519: Patient, primary colorectal tumor and liver metastases factors which influence survival after liver metastasectomy and therefore should be considered at the preoperative tumor board

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6519-6519

2020

Volltextzugriff (PDF)

ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO

Annals of surgery, 2021-03, Vol.273 (3), p.442-448

2021

Volltextzugriff (PDF)

Inhibition of mTOR Suppresses Experimental Liver Tumours

Anticancer research, 2005-03, Vol.25 (2A), p.789-793

2005

Volltextzugriff (PDF)

Risk Factors for Postoperative Complications Following Resection of Colorectal Liver Metastases and the Impact on Long-Term Survival: A Population-Based National Cohort Study

World journal of surgery, 2023-09, Vol.47 (9), p.2230-2240

2023

Volltextzugriff (PDF)

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

Annals of surgery, 2020-11, Vol.272 (5), p.855-862

2020

Volltextzugriff (PDF)

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Transplantation, 2016-01, Vol.100 (1), p.116-125

2016

Volltextzugriff (PDF)

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)

Journal of clinical oncology, 2023-06, Vol.41 (16), p.3042-3050

2023

Volltextzugriff (PDF)

Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9533-9533

2024

Volltextzugriff (PDF)

Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9532-9532

2024

Volltextzugriff (PDF)

A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial)

JOURNAL OF CLINICAL ONCOLOGY, 2023, Vol.41 (16_suppl), p.9533-9533

2023

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis:Master (3349 titles)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Outcomes of Simultaneous Resections and Classical Strategy for Synchronous Colorectal Liver Metastases in Sweden: A Nationwide Study with Special Reference to Major Liver Resections

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation

Phase 1 Trial With the Cell-Based Immune Primer Ilixadencel, Alone, and Combined With Sorafenib, in Advanced Hepatocellular Carcinoma

Argipressin for prevention of blood loss during liver resection: a study protocol for a randomised, placebo-controlled, double-blinded trial (ARG-01)

Characterization of brown adipose tissue in the human perirenal depot

Checkpoint Inhibition Causing Complete Remission of Metastatic Combined Hepatocellular-Cholangiocarcinoma after Hepatic Resection

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer

The Impact of Changed Strategies for Patients with Cholangiocarcinoma in This Millenium

Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial

Simulation Model of Microsphere Distribution for Selective Internal Radiation Therapy Agrees With Observations

Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO Trial

Autoradiography and biopsy measurements of a resected hepatocellular carcinoma treated with 90 yttrium radioembolization demonstrate large absorbed dose heterogeneities

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study

ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)

Abstract 6519: Patient, primary colorectal tumor and liver metastases factors which influence survival after liver metastasectomy and therefore should be considered at the preoperative tumor board

ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO

Inhibition of mTOR Suppresses Experimental Liver Tumours

Risk Factors for Postoperative Complications Following Resection of Colorectal Liver Metastases and the Impact on Long-Term Survival: A Population-Based National Cohort Study

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)

Overall survival after isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM II trial)

Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial)

A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial)

Aktive Filter

Suchergebnisse filtern